Just a quick note: we’ll host a webinar on January 30th to discuss key market predictions based on “The Digital Brain Health Market 2012–2020: Web-based, mobile and biometrics-based technology to assess, monitor and enhance cognition and brain functioning”, our new market report.
Here are 10 predictions, many of which will likely be realized before the end of 2013: Read the rest of this entry »
By: Alvaro Fernandez
Dear Mr or Mrs Next US President,
We are glad to welcome you to our blog carnival. After a short hiatus, Encephalon is back and gathering steam. We have prepared this “revival” edition just for you, so you can be well informed and impress us all during the upcoming Sciencedebate 2008.
Without further ado, let’s proceed to the questions posed by 24 bloggers on neuroscience and psychology issues. We hope they provide, at the very least, good mental stimulation for you and your advisors.
Do I deserve to vote even if I don’t have Free Will? (Marc at Neuroscientifically Challenged).
If culture sculpts our brains, what can our brains do to refine our culture first? (Stephanie at Brains On Purpose).
Is God more than a flying brain? (Jessica at bioephemera).
Is Your brain really reading This? (Pete at Brain Hammer).
A Few Intrusive Questions
Do you play any musical instrument? (Megan at SharpBrains).
Read the rest of this entry »
By: Alvaro Fernandez
Not a day goes by without a significant depression-related announcement. Yesterday, one could read that Older Women More Likely to Suffer Depression (than Older Men; in the Washington Post). Today, we see that St. Jude Starting Trial On Brain Stimulation For Depression (CNN). A few days ago, Blue Cross of California Launched Maternity Depression Program (press release).
Time to step back and ask ourselves questions such as, “What is going On”, “What is Depression”, “What Treatments Work, and What is the Latest Research”. Fortunately, thanks to our collaboration with Greater Good Magazine, Jill Suttie offers a fascinating answers to those questions-and more. Enjoy.
Closing the Circuit
Helen Mayberg’s research could revolutionize depression treatment.
— By Jill Suttie.
At some point in their lives, 5 to 12 percent of American men and 10–25 percent of women will suffer an episode of depression, making it the most commonly diagnosed mental disorder today. Unlike normal sadness, which passes with time, depression feels unstoppable and causes people to lose interest in nearly all activities. Because it affects a person’s ability to eat, sleep, work, and function normally, it exacts a huge cost on the economy, estimated at $30 billion dollars annually. The cost in human suffering cannot be measured.
Millions of people diagnosed with depression turn to medication as a treatment, and many of the most popular Read the rest of this entry »